Korecyte Bio
Biotechnology Research • 
London, England, United Kingdom • 1-10 Employees
Company overview
| Headquarters | London, England, United Kingdom |
| Website | |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 1-10 |
| Socials |
Key Contact at Korecyte Bio
Léon Spijkers
Chief Executive Officer
About Korecyte Bio
Korecyte Bio is a cell therapy startup based in London, the United Kingdom and was established in 2023/2024. Our mission is to release our next-generation cell therapy tool to render CAR-based therapies much safer and more effective. Our internal developments focus on CAR-T products which can safely target a range of solid cancers and deliver improved outcomes for patients with cancer.
Korecyte Bio revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Korecyte Bio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Korecyte Bio has never raised funding before.
Korecyte Bio Tech Stack
Discover the technologies and tools that power Korecyte Bio's digital infrastructure, from frameworks to analytics platforms.
Font scripts
JavaScript libraries
Programming languages
Blogs
Analytics
SEO
Tag managers
Reverse proxies
WordPress plugins
Caching
Page builders
Poland
Brazil
United States
Japan
United Arab Emirates
Italy
CanadaFrequently asked questions
4.8
40,000 users
